Skip to main content

Mental imagery

Imagery in Early Stages of Dementia

University of West Attica
Mental imagery

Information about the intervention that will be tested in the study

Name of the intervention

Mental imagery – this is a technique which involves envisioning motor actions without actual execution


Participants will undergo a 45-minute mental imagery session sitting in a quiet place after the end of an exercise program session. The content of every mental imagery session is alike with the content of the exercise program session. That means that every session includes imagery of the same exercises of the exercise program performed earlier by the participant.

Will all participants receive the same intervention?

Participants will be selected at random to either receive one of the following options:

  • Mental imagery and exercise program
  • Only exercise program (this is a control group)
  • Neither mental imagery nor exercise program (this is another control group).

Information about participating in the study

What are the researchers trying to find out?

The purpose of the study is to investigate the effectiveness of mental imagery in motor and cognitive rehabilitation in people with early stage of dementia.

How long will the study last?

12 weeks (2 sessions/week)

What your involvement will entail?
  • Participants will be asked to complete several questionnaires and functional tests to evaluate balance, functional status, cognitive ability, depression and quality of life.

Further information on the procedures, tests and number of visits can be obtained from the study team.

Who can participate in this study?

Who can participate in the study?

To take part in the study, participants must:

  • Be 65 to 95 years old
  • Have a diagnosis of early stage of dementia
  • Have good oral and written speech
  • Be ambulatory.
Who cannot participate in the study?

People cannot take part in the study if they have:

  • Late stage of dementia
  • Psychiatric problems
  • Serious health problems
  • Not able to walk.

The above list is not exhaustive. It includes the most common conditions and diseases that might exclude people from the study.

Information for your doctor identifier


Study contact information

Anna Christakou +306977370284

Vasiliki Sakellari +306979033952

Link to full text

The information contained in this document is based on information available on public registries (e.g. website) on January 2023.

This document has been reviewed by the institution running this trial.


Alzheimer Europe's Clinical Trials Watch database was developed as part of the 2018 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).

Alzheimer Europe gratefully acknowledges the support of its corporate sponsors for the update and maintenance of the database.